Monthly Archives: August 2020

Cancer Biopharmaceuticals Market 2020 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2025

A New Market Study, titled “Cancer Biopharmaceuticals Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

Pune, India – August 11, 2020 /MarketersMedia/

Summary

A New Market Study, titled “Cancer Biopharmaceuticals Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

This report provides in depth study of “Cancer Biopharmaceuticals Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Cancer Biopharmaceuticals Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This market report offers a comprehensive analysis of the global Cancer Biopharmaceuticals market. This report focused on Cancer Biopharmaceuticals market past and present growth globally. Global research on Global Cancer Biopharmaceuticals Industry presents a market overview, product details, classification, market concentration, and maturity study. The market value and growth rate from 2019-2025 along with industry size estimates are explained.

Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4896275-global-cancer-biopharmaceuticals-market-size-status-and-forecast-2020-2026

This report focuses on the global Cancer Biopharmaceuticals status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Biopharmaceuticals development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Sanofi
Johnson & Johnson
Pfizer
Novartis
Merck
GlaxoSmithKline
Eli Lilly
Agios Pharmaceuticals
Bristol-Myers Squibb
AstraZeneca
Mylan
LEO Pharma
Boehringer Ingelheim
Alexion Pharmaceuticals
Elusys Therapeutics

Market segment by Type, the product can be split into
Biologics
Biosimilars
Market segment by Application, split into
Liquid Cancers
Solid Cancers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cancer Biopharmaceuticals status, future forecast, growth opportunity, key market and key players.
To present the Cancer Biopharmaceuticals development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Biopharmaceuticals are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

At Any Query @ https://www.wiseguyreports.com/enquiry/4896275-global-cancer-biopharmaceuticals-market-size-status-and-forecast-2020-2026

Major Key Points in Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Biopharmaceuticals Revenue
1.4 Market Analysis by Type
1.4.1 Global Cancer Biopharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biologics
1.4.3 Biosimilars
1.5 Market by Application
1.5.1 Global Cancer Biopharmaceuticals Market Share by Application: 2020 VS 2026
1.5.2 Liquid Cancers
1.5.3 Solid Cancers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Cancer Biopharmaceuticals Market Perspective (2015-2026)
2.2 Cancer Biopharmaceuticals Growth Trends by Regions
2.2.1 Cancer Biopharmaceuticals Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Biopharmaceuticals Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Biopharmaceuticals Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Biopharmaceuticals Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Biopharmaceuticals Players (Opinion Leaders)

….

13Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview and Its Total Revenue
13.1.3 Sanofi Cancer Biopharmaceuticals Introduction
13.1.4 Sanofi Revenue in Cancer Biopharmaceuticals Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
13.2.3 Johnson & Johnson Cancer Biopharmaceuticals Introduction
13.2.4 Johnson & Johnson Revenue in Cancer Biopharmaceuticals Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview and Its Total Revenue
13.3.3 Pfizer Cancer Biopharmaceuticals Introduction
13.3.4 Pfizer Revenue in Cancer Biopharmaceuticals Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview and Its Total Revenue
13.4.3 Novartis Cancer Biopharmaceuticals Introduction
13.4.4 Novartis Revenue in Cancer Biopharmaceuticals Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview and Its Total Revenue
13.5.3 Merck Cancer Biopharmaceuticals Introduction
13.5.4 Merck Revenue in Cancer Biopharmaceuticals Business (2015-2020)
13.5.5 Merck Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.6.3 GlaxoSmithKline Cancer Biopharmaceuticals Introduction
13.6.4 GlaxoSmithKline Revenue in Cancer Biopharmaceuticals Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Eli Lilly
13.7.1 Eli Lilly Company Details
13.7.2 Eli Lilly Business Overview and Its Total Revenue
13.7.3 Eli Lilly Cancer Biopharmaceuticals Introduction
13.7.4 Eli Lilly Revenue in Cancer Biopharmaceuticals Business (2015-2020)
13.7.5 Eli Lilly Recent Development
13.8 Agios Pharmaceuticals
13.8.1 Agios Pharmaceuticals Company Details
13.8.2 Agios Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Agios Pharmaceuticals Cancer Biopharmaceuticals Introduction
13.8.4 Agios Pharmaceuticals Revenue in Cancer Biopharmaceuticals Business (2015-2020)
13.8.5 Agios Pharmaceuticals Recent Development
13.9 Bristol-Myers Squibb
13.9.1 Bristol-Myers Squibb Company Details
13.9.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.9.3 Bristol-Myers Squibb Cancer Biopharmaceuticals Introduction
13.9.4 Bristol-Myers Squibb Revenue in Cancer Biopharmaceuticals Business (2015-2020)
13.9.5 Bristol-Myers Squibb Recent Development
13.10 AstraZeneca
13.10.1 AstraZeneca Company Details
13.10.2 AstraZeneca Business Overview and Its Total Revenue
13.10.3 AstraZeneca Cancer Biopharmaceuticals Introduction
13.10.4 AstraZeneca Revenue in Cancer Biopharmaceuticals Business (2015-2020)
13.10.5 AstraZeneca Recent Development
13.11 Mylan
13.12 LEO Pharma
13.13 Boehringer Ingelheim
13.14 Alexion Pharmaceuticals
13.15 Elusys Therapeutics

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers, , Pune – 411028, , Maharashtra, India
Phone: 6282580070
Website: https://www.wiseguyreports.com/sample-request/4896275-global-cancer-biopharmaceuticals-market-size-status-and-forecast-2020-2026

Source URL: https://marketersmedia.com/cancer-biopharmaceuticals-market-2020-global-trends-market-share-industry-size-growth-opportunities-and-forecast-to-2025/88972303

Source: MarketersMedia

Release ID: 88972303

The Kevin David Experience (Ninja Podcast) is Now on the List of the Top 25 Business Podcasts

Kevin David Speaks with Some of Today's Most Successful Entrepreneurs on his Popular Podcast

LOS ANGELES, CA / ACCESSWIRE / August 11, 2020 / Kevin David, a worldwide leader on eCommerce, entrepreneurship, digital media and social business, is pleased to announce that The Kevin David Experience (Ninja Podcast) is now on the list of the Top 25 Business Podcasts.

To learn more about Kevin and the Kevin David courses that he offers to budding entrepreneurs to teach them how to build successful online businesses, please check out https://officialkevindavid.com/.

As Kevin David noted, The Kevin David Experience (Ninja Podcast) has grown rapidly in popularity; in the last 30 days, the podcast was downloaded about 29,000 times.

During the podcast, Kevin David chats with a variety of successful entrepreneurs who have achieved a great deal of success in today's business world. He also offers his listeners uncut and practical business knowledge, tips, advice and stories that help illustrate how Kevin went from having virtually nothing to making 8 figures as an entrepreneur.

Who is Kevin David?

To learn more about Kevin David, please check out this YouTube video: https://youtu.be/pbk3k-4tYjI

Kevin David On Finding A Mentor:

"If you're looking for real advice from someone who failed countless times on his path to success; if you're looking for a little commute, workout, solo or ‘me' time motivation, you came to the right place," Kevin David said, adding that in each episode, he names strategies, tools, and tactics that any beginner or expert can implement into their everyday life and business.

The fact that The Kevin David Experience (Ninja Podcast) is now on the list of Top 25 Business Podcasts will not surprise the tens of thousands of people who regularly download and listen to Kevin and his interesting guests. Since the day he first launched the podcast, Kevin has strived to feature top-notch businesses and highly useful interviews that are chock full of actionable advice.

For instance, a recent podcast titled "How to Stop Bad Habits for Good with 3 Simple Steps" created quite a positive buzz with listeners who were eager to hear what Kevin and his guest, Aneela Idnani, co-founder of HabitAware, had to say on the subject. HabitAware sells "smart bracelets" that send a vibration to the wearer to alert him or her to certain behaviors like pulling on hair or eyebrows or fingernail biting.

"Aneela joined us for this podcast to talk more about stopping unwanted behaviors and what inspired her to start such an initiative," Kevin David said.

About Kevin David:

Kevin David is an internationally renowned leader on eCommerce, entrepreneurship, social media, and digital business. He quickly grew from a 9-5 accountant to creating multiple 8 figure businesses. For more information, please visit https://officialkevindavid.com/.

Contact:

Kevin David
hulse.kevin11@gmail.com
18004252401

SOURCE: Kevin David

ReleaseID: 601164

Walter Vann, Long Beach, California Based Realtor And Family Man, Shares How His Own Values & Family Background Influence His Ability To Provide Exceptional Service To His Clients

LONG BEACH, CA / ACCESSWIRE / August 11, 2020 / "In order for me to protect my family's future I have to protect my client's future." Real Estate agent Walter Vann's family values impact each transaction he shares with his real estate clients.

Walter Vann grew up watching his parents work endless hours to provide for him and his four siblings. Walter, born in New York, is the son of immigrant parents from Cambodia. Knowing first hand how hard his parents worked, it was only natural that Walter derived his own strong work ethic starting at a young age.

His journey into real estate began nearly a decade ago. After years of employment in the construction field working endless hours with a commitment in mind to provide for his own family, Walter realized that his kids were growing up similar to his own upbringing, with no parents around. This was the moment when he knew something had to change. Inspired by a TV show, Los Angeles Million Dollar Listing, Walter changed career paths from construction into real estate. Within the year, he obtained his license and quickly learned the ins and outs of real estate and marketing from top real estate and digital marketing coaches, brokers and mentors. Walter formed a partnership with other like minded realtors and started the next chapter of his journey at eXp Realty.

Over the years, Walter continuously thought back to the sage advice he'd been given by his father. "Be scared of being comfortable because if you're comfortable you're not growing. Being comfortable about being uncomfortable gives you the ability to keep improving, and is a great trait leaders are able to show." The thirst for self improvement and the ability to be humble and learn from everybody around him, including his partners is a reflection of Walter's father being a gateway into Walter's own journey in personal development, serving as a constant source of encouragement and inspiration, he prompted Walter to reach for more and to not consider failure as an option. As a result, when Walter puts his mind to something, little can stop him.

Through it all, Walter seeks to keep his family oriented values as the center of his business and service to clients, acutely aware of the example he is setting for his own children in each client interaction. Walter believes those in the industry should be servant leaders for their clients. They should sincerely care about you and your family's future, not just closing the transaction. This is a belief that Walter holds dear and reminds himself every morning at 5am. As he grabs his coffee, takes a quiet peek at his kids sleeping, and starts his day knowing that in order to protect his kids' future and happiness, he has to protect his clients' investment and future. Through this mindset, he is extremely grateful to have earned his clients trust and friendship over the course of his career.

During his construction career, due to extensive travel as is common in the industry, Walter missed many 1st milestones with his children. Now in his late 30's, with his children being a little older, Walter has a keen appreciation for just how precious each moment in life is and does not take anything for granted. This notion is what sparked his latest endeavor to add a unique service, unseen in real estate, and which has already received exciting feedback from home buyers. In this service, Walter and his videographer record footage of each step of the home buying process, from initial views, to inspections all the way through closing on the home. This results in a beautiful, incredibly emotional video montage the family can cherish for years to come. Similar to those a client might have of their prom or wedding. Working with Walter and his team is truly a unique and unparalleled experience, as he believes this is what each family and individual deserves when they realize their dream of home ownership. If you're interested in working with Walter to buy or sell a home, or in joining his incredible team of realtors, visit www.LBdigitalrealtor.com.

Contact Name: Walter Vann
Business Name: Long Beach Digital Realtor
Address: Long Beach, California
Phone Number: (562) 200-2221
Contact Email Here
Website Link: https://www.lbdigitalrealtor.com/

SOURCE: Walter Vann

ReleaseID: 600572

Creative Biogene Launches Transgenic Plant Service to Improve The Ability of Transgenic Plant to Resist Pests and Diseases

Creative Biogene announced today the release of its professional transgenic plant service.

New York, USA – August 11, 2020 /MarketersMedia/

Creative Biogene, the world’s leading biotechnology products and services provider, is dedicated to supporting worldwide customers in biological and biochemical fields, announced today the release of its professional transgenic plant service, the professional genetic research team enables to provide customers with multi-faceted, high-quality, low-cost transgenic plant service to meet different needs.

The transgenic plant service offered by Creative Biogene can guarantee complete experiment reports, including specific experiment procedures, test results and substance inspection reports, as well as experimental products offered(if applicable), such as vectors, transformed plant-positive seedlings or seeds.

Highlights of transgenic plant service offered by Creative Biogene:
1, High quality: Professional technical team will explore the best experimental conditions according to the specific situations and provide the best service.
2, All-round services: One-stop services from gene molecular cloning, vector construction, plant transformation to molecular characterization and functional identification of transgenic plants. Customers can customize according to various needs.
3, High efficiency: Mature and complete experimental system and an experienced research team to ensure the completion of high-quality services in the shortest time.
4, The most comprehensive services at competitive prices

Creative Biogene’s advanced molecular biology platform has provided hundreds of plant expression vectors for global customers, including pCAMBIA series, pEarleyGate series, pBI series, pRI series, and pGreen series. These have been successfully used in gene overexpression, targeted expression, inducible expression, gene silencing, gene editing, gene stacking and promoter activity analysis projects. Importantly, all of plasmid vectors are optimized for high copy number replication in E. coli and achieve efficient plant delivery and gene expression.

In the past decades, Creative Biogene has focused on conventional plant tissue culture and genetic transformation to provide customers with high-quality services. It has successfully transformed major agronomic crops such as rice, corn, cotton, wheat, barley and model plants such as Arabidopsis and tobacco. In addition, Creative Biogene’s employees have extensive experience in developing species for transformation methods, and always utilize the most advanced equipment and professional scientists to work closely with customers to provide satisfactory plant transformation services.

In addition, Creative Biogene has gathered many senior experts to provide customers with molecular characterization testing services with stable quality and reasonable prices. With a complete transformation system and many years of service experience, Creative Biogene can supply mature screening and testing technology for genetically modified plants, and can provide molecular identification testing services at all levels (DNA, RNA and protein).

“Creative Biogene aims to provide the most affordable, high-quality customized vector construction and modification services, meanwhile, we also provide plant transformation services based different plant varieties for customers around the world” said Marcia Brady, the marketing director of Creative Biogene, she added, “We will select suitable molecular characterization test methods for different species according to your various needs to ensure objective and reliable results.”

About Creative Biogene
Creative Biogene, as a top-of-its-kind company that holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.

Contact Info:
Name: Macia Brady
Email: Send Email
Organization: Creative Biogene
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA
Phone: 06316197922
Website: https://www.creative-biogene.com/

Source URL: https://marketersmedia.com/creative-biogene-launches-transgenic-plant-service-to-improve-the-ability-of-transgenic-plant-to-resist-pests-and-diseases/88972044

Source: MarketersMedia

Release ID: 88972044

Perimeter Medical Imaging AI Announces Listing on Frankfurt Stock Exchange

DALLAS, TX / ACCESSWIRE / August 11, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK) today announced the listing of its common shares on the Frankfurt Stock Exchange (the "FSE") under the trading symbol "4PC" (FSE:4PC) which can be found at: https://www.boerse-frankfurt.de/equity/perimeter-med-imag-ai. Perimeter's common shares listed on the TSX Venture will continue to trade under the ticker symbol "PINK."

Jeremy Sobotta, Perimeter's President and CFO, stated, "We are pleased to announce our listing on the Frankfurt Stock Exchange as this creates an opportunity to increase trading liquidity and broaden our shareholder base. We believe there is a strong demand for biotech and medtech companies in Europe, as we have already received interest in Perimeter from European-based shareholders."

Mr. Sobotta continued, "This secondary listing is another important milestone that comes at an exciting time as we execute our clinical studies supporting the development and validation of our ImgAssist AI software in breast cancer surgery and accelerate our commercialization plans for our innovative, point-of-care medical imaging system, OTIS™, which provides surgeons with real-time, ultra-high resolution, sub-surface images of extracted tissues."

About Perimeter Medical Imaging AI, Inc.
Perimeter Medical Imaging AI (TSXV:PINK)(FSE:4PC) is a Toronto-based company with U.S. headquarters in Dallas, Texas that is developing, with plans to commercialize, advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. Perimeter's OTIS™ platform is a point-of-care imaging system that provides clinicians with real-time, ultra-high-resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen.

The ability to visualize microscopic tissue structures during a clinical procedure in addition to standard of care tissue assessment for decision making during the procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system. Perimeter's OTIS™ platform is cleared by FDA as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization, with image review manipulation software for identifying and annotating regions of interest. In addition, Perimeter is developing advanced artificial intelligence/machine learning image assessment tools intended to increase the efficiency of review.

Perimeter's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month by the Canadian Cancer Society and the American Cancer Society, driving home the company's dedication to helping surgeons, radiologists and pathologists use Perimeter's imaging technology and AI (Artificial Intelligence) in the fight against breast cancer, which is estimated to account for 30% of all female cancer diagnoses this year.

CONTACT:
Jodi Regts
Corporate Communications / Investor Relations
Perimeter Medical Imaging AI, Inc.
+1 778-999-5634
media@perimetermed.com

NEITHER THE TSXV NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Forward-Looking Statements:
This news release contains statements that may constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may", "would", "could", "will", "likely", "believe", "expect", "anticipate", "intend", "plan", "estimate" and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may include, among others, statements regarding the timing and results from clinical studies, commercialization plans, future liquidity or investment in Perimeter's common shares, or the assumptions underlying any of the foregoing.

Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political and social uncertainties and contingencies.

In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described the joint information circular dated May 12, 2020, prepared in respect of the securityholder meetings held on June 17, 2020 a copy of which is available on Perimeter's SEDAR profile at www.sedar.com, and could cause actual events or results to differ materially from those projected in any forward-looking statements. In particular, we note the risk that our technology may not achieve the anticipated benefits in terms of surgical outcomes. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events or circumstances or otherwise, except if required by applicable laws.

SOURCE: Perimeter Medical Imaging

ReleaseID: 601110

Family Levels Up Daily Routine with Surviveware Large First Aid Kit

Surviveware’s Large First Aid Kit Provides Premium Preparedness

Woodbridge, United States – August 11, 2020 /MarketersMedia/

Surviveware, a leading retailer of preparedness and survival gear, offers a solution to any prepper’s safety and preparedness needs— the Surviveware Large First Aid Kit, which provides maximum protection for any outdoor or emergency woe.

This expanded survival first aid kit is durable and water-resistant. Thanks to its 600D polyester case, heavy-duty zippers, and MOLLE-strap system, kit owners are assured that this pack can withstand constant wear and tear, not to mention rough usage. For an extra layer of protection, laminate bags hold the provisions, keeping everything fresh and bone-dry. The MOLLE-compatible straps lock the pack in place, whether to a rucksack, go-bag, headrest, bicycle, or camp chair. This system provides easy accessibility to the bag and ensures the kit is retrieved in an emergency.

The Large First Aid Kit contains 200 life-saving provisions for handling wounds, shock, trauma, concussion, bruises, twisted ligaments, among other common injuries. For minor to moderately severe injuries, the outdoor first aid kit comes with antiseptic and cleansing wipes, as well as trauma shears, sting relief wipes, and hydrogels.

Apart from wound care items, this survival first aid kit also contains medical tools such as tweezers, nitrile gloves, safety pins, an emergency blanket, and splinter probes, a CPR kit and mini first aid kit. The advanced first aid handbook is a handy informational guide for users to refer to as a refresher. Despite having a large supply of first aid items inside, there is still room for additional provisions such as Epi-pens, inhalers, or a tourniquet, so that kit owners can customize this large first aid kit to suit their varying preparedness needs.

A favorite feature of this Surviveware outdoor first aid kit is its structure. The supplies are divided into labeled compartments, organizing each item for easy retrieval. The compartment labels note the items’ name, use, and quantity, making it easy for users to quickly glance at the kit and retrieve what items are needed. The kit is user-friendly, even for bystanders and children.

In the following review written by Miriam, a Surviveware Amazon customer, she shared her impression of the Surviveware Large First Aid Kit, and how she’s incorporated it into her family’s lifestyle:

“This is a very well thought and laid out first aid kit. For our family’s needs, it is 99% of the way there, much higher than any other kit I’ve found. Like any pre-made kit, we have added a few items to it to cover some very specific medical needs that our children have (i.g. EpiPen). It was no problem at all because this bag has a little extra room to pack them in.

The extra small 50-piece kit that was also included is now in my work backpack. I make frequent trips to downtown Boston for work, and it seems like a handy item to have with me at all times now.”

Choose the kit that provides total protection, anywhere, everywhere. Get the Surviveware Large First Aid Kit today by clicking here.

Contact Info:
Name: Amanda Condry
Email: Send Email
Organization: Surviveware
Phone: 703-910-5188
Website: https://surviveware.com

Source URL: https://marketersmedia.com/family-levels-up-daily-routine-with-surviveware-large-first-aid-kit/88971703

Source: MarketersMedia

Release ID: 88971703

TRUX Continues Its Growth Trajectory in Q2 Despite Challenges Presented by Ongoing COVID-19 Pandemic

Number of Drivers Working Each Day with Dump Truck Logistics Startup More Than Doubles; Company Expands into Seven New Markets

WALTHAM, MA / ACCESSWIRE / August 11, 2020 / TRUX™, the leader in dump truck logistics technology, has continued to grow during the COVID-19 pandemic with recent product launches and enhanced features aimed at helping the construction industry facilitate essential work and operate more efficiently. Over the past year, TRUX expanded its presence into 24 states across the U.S. and saw a 121 percent increase in the number of haulers using its logistics platform.

Innovative deployment of the TRUX platform has fueled its growth geographically, specifically in the southeast including Florida, South Carolina, and Georgia in 2020. TRUX continues to maintain the nation's largest technology-enabled network of dump truck drivers, with more than 20,000 approved drivers using its platform. Each month, over 750 new drivers take their first shift on the platform, delivering materials to active construction sites. Since its inception, over 85 million miles have been logged onto the TRUX platform and the company has processed more than 50,000 invoices for its contractors, helping each customer save an estimated 700 hours per year on processing invoices alone.

In July 2020, TRUX launched Powered by TRUX, its enterprise-level logistics service for material producers, which saw an 80+ percent adoption rate after three weeks; and earlier this summer, TRUX released its new DOT-ready contactless ticketing solution for safer job sites. Additional product enhancements launched by TRUX this year include:

Digital Dispatching and Fleet Management tools, which allow for better customer service and robust asset tracking
In-depth Cycle-Time Analysis, which gives dispatchers a new level of transparency into real-time performance
Order Delivery Tracker, which has enabled thousands of contractors to track deliveries of material in real-time on their job-sites

"The challenges facing the construction industry are significant and only getting more complex as the COVID-19 pandemic continues," said Bart Ronan, CEO of TRUX. "From the beginning, we've remained steadfast in our commitment to modernize construction logistics. Our innovative approach to on-site deployment and onboarding has made the adoption of our logistics solutions straightforward for haulers and contractors even in today's demanding environment."

Ronan continued, "We invest in our technology continuously, and since June, we've launched two new solutions – 'Powered by TRUX' and contactless ticketing – to help meet the unique and changing needs of our valued customers. Our goal is to continue to innovate and expand our product offerings as we remain committed to offering our partners and customers market-leading logistics solutions that benefit the construction industry as a whole."

For more information about TRUX and the company's modern construction logistics solutions, visit TRUXnow.com.

About TRUX
TRUX is a multi-sided platform providing an open marketplace and enterprise logistics management solution that connects truckers, contractors, and material producers throughout North America. TRUX offers the nation's largest technology-enabled dump truck network, with over 20,000 approved dump truck drivers. The company's complete dump truck management solution is transforming the logistics of a $50 billion industry that has largely been left behind by technology. TRUX works with contractors, individual owner/operators, and corporations of all sizes to increase the efficiency of the industry and effect positive social change by reducing the carbon imprint in construction through smarter logistics.

MEDIA CONTACT:

Paula Slotkin
Slotkin Communications
781-248-9696
paula@slotkincommunications.com

SOURCE: TRUX

ReleaseID: 601055

Mullen Technologies To Present at J.P. Morgan Virtual Auto Conference on Wednesday, August 12th

BREA, CA / ACCESSWIRE / August 11, 2020 / Mullen Technologies, Inc. ("Mullen" or the "Company"), an emerging electric vehicle ("EV") manufacturer and technology company, which previously announced a definitive agreement to merge with Net Element, Inc. (NASDAQ:NETE), in a stock-for-stock reverse merger in which Mullen's stockholders will receive a majority of the outstanding stock in the post-merger company, announced today that the Company will present at the J.P. Morgan Virtual Auto Conference on Wednesday, August 12th at 9:20 a.m. Eastern Time. At the presentation, David Michery, Mullen's Chief Executive Officer, will outline the Company's path to electric vehicle production in 2022, and discuss the Company's proprietary technology platform.

Investors interested in listening to the Company's presentation may access it live at J.P Morgan/MullenTech There will be a question and answer session for conference participants at the conclusion of the formal presentation.

The conference will feature more than 50 companies in the auto sector and will include presentations, one-on-one meetings and panel discussions.

About Mullen Technologies
Mullen Technologies is a Southern California-based licensed vehicle manufacturer that operates in various verticals of the businesses focusing in the automotive industry: Mullen Automotive, Mullen Energy, Mullen Auto Sales, Mullen Funding Corp., and CarHub. Each of these divisions provide Mullen with diversity of different products and services within the automotive industry. For more information, please visit: www.MullenUSA.com.

Forward-Looking Statements
This press release contains "forward-looking statements." Words such as "may," "should," "could," "would," "predicts," "potential," "continue," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar expressions, as well as statements in future tense, often signify forward-looking statements. These forward-looking statements include, without limitation, statements relating the proposed production date of the MX-05 midsize and perceived advantages and future deployment of the solid-state polymer battery technology. These forward-looking statements are, by their nature, subject to significant risks and uncertainties.

Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved. Forward-looking statements are based on information that the Company has when those statements are made or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements, including any changes in the laws, rules and regulations relating to any aspects of the Company's business operations, general economic, market and business conditions, including capital market developments, the actions and developments of the Company's competitors and the effects of competition in the EV industry on the demand for, and price of, the Company's current and proposed products and services, various business opportunities that the Company, and factors beyond the Company's control. As a result of these and other risks, uncertainties and assumptions, forward-looking events and circumstances discussed herein might not occur in the way the Company expects, or at all. Accordingly, you should not place reliance on any forward-looking information or statements. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. All forward-looking statements herein are qualified by reference to the cautionary statements set forth in this section.

CONTACT:
Mullen Technologies, Inc.
+1 (714) 613-1900
www.MullenUSA.com
marketing@mullenusa.com

SOURCE: Mullen Technologies, Inc.

ReleaseID: 601125

Pharmacy Instructor at Asher College of Las Vegas Recognized

Asher College is proud to announce that its Pharmacy instructor, Mary Jane De La Cruz, has been recognized by the Pharmacy Technician Certification Board (PTCB).

Las Vegas, NV – August 11, 2020

Asher College is proud to announce that Pharmacy instructor, Mary Jane De La Cruz, has been recognized by the Pharmacy Technician Certification Board (PTCB) for her contributions to the field of Pharmacy. De La Cruz has been with Asher since 2017 and works at the Las Vegas campus of Asher College.

In July 2020, Pharmacy instructor, Mary Jane De La Cruz, was acknowledged by the Pharmacy Technician Certification Board (PTCB) for her assistance in creating and reviewing test content for the Pharmacy Technician Certification Exam (PTCE). De La Cruz was one of eight individuals selected by the PTCB in June 2020 to attend a remote item writing mentors meeting. The purpose was to review and develop new test questions for the national Pharmacy Technician Certification Exam (PTCE).

In its letter of appreciation, De La Cruz was commended for the valuable contributions she made through her participation in the recent item writing mentors meeting. The PTCB explicitly acknowledged Ms. De La Cruz’s outstanding commitment to pharmacy practice. Asher College, as well, recognizes De La Cruz’s contributions to the field of Pharmacy and is proud to have her as a valuable member of faculty.

Mary Jane De La Cruz brings almost thirty years of experience in pharmaceutical medicine to Asher’s staff. De La Cruz holds a Bachelor of Science degree in Pharmacy and a Master of Science degree in Pharmacy and has been teaching since 1991. In addition to being one of only eight individuals recently selected to develop and review the PTCE, De La Cruz has also been recruited to review textbook manuscripts, co-authored four pharmacy manuals, published her research in several academic journals, and authored two books on Pharmacy Science: Pharmaceutical Jurisprudence and Ethics and Pharmaceutical Care.

Asher’ College’s Pharmacy Technology program is a PTCB- recognized education/training program that teaches students the essential knowledge and practical skills necessary to succeed in entry-level positions. Students learn how to fill prescriptions under the direct supervision of a pharmacist, utilize relevant software applications, recognize the classifications of drugs and scheduled drugs, understand brand, generic, and OTC (over the counter) medications, adhere to HIPAA privacy regulations and comprehend and perform insurance procedures.

Asher offers an Associate of Applied Science degree program as well as a shorter certificate program. The certification portion can be completed in as few as 45 weeks. The program allows students to pursue their Pharmacy Technician certification from the Pharmacy Technician Certification Board (PTCB), register for their license with the Nevada State Board of Pharmacy, and begin working in their field while still finishing up the additional courses for the degree. Asher College also offers these programs at their other locations in Dallas, TX and Sacramento, CA. Visit the Asher website Pharmacy program page for more information.

###

Facebook: https://www.facebook.com/ashercollegelasvegas

Youtube: https://www.youtube.com/ashercollege

About Us: Founded in 1998, Asher College is accredited through ACCET, the Accrediting Council for Continuing Education and Training. Asher has three locations: Sacramento, California; Las Vegas, Nevada; and Dallas, Texas.

Contact Info:
Name: Kim Gasper
Email: Send Email
Organization: Asher College
Address: 6029 W. Charleston Blvd, Las Vegas, NV, 89146
Phone: 702-323-0853
Website: http://www.Asher.edu

Release ID: 88972264

Grande West To Announce 2020 Second Quarter Results August 24

VANCOUVER, BC / ACCESSWIRE / August 11, 2020 / Grande West Transportation Group Inc. (TSXV:BUS)(OTC PINK:GWTNF) ("Grande West" or the "Company"), a Canadian manufacturer of mid-sized multi-purpose transit vehicles for sale in Canada and the United States, announced today that 2020 second quarter financial results will be released after market close on Monday, August 24, 2020.

A conference call for interested listeners will be held on Tuesday, August 25 at 11:00 AM EST. The call-in number is (877) 407-0782 or (201) 689-8567, the webcast can be accessed at https://www.webcaster4.com/Webcast/Page/2233/36612. A replay of the call will be available for 30 days at the webcast link or by calling (877) 481-4010 and entering PIN# 36612.

About Grande West Transportation Group
Grande West Transportation is a Canadian company that designs and engineers mid-size multi-purpose transit vehicles for public and commercial enterprises. Grande West utilizes world class manufacturing partners to produce the Purpose-Built Vicinity bus available in clean diesel, gas and CNG drive systems. An electric propulsion drive system is currently under development.

The Company has been successful in supplying Canadian municipal transportation agencies and private operators with new buses. Grande West is compliant to Buy America certification, and along with Alliance Bus Group, its exclusive US distributor, they are actively pursuing opportunities in public and private transit fleet operations that would benefit from Grande West's vehicles.

For further information please contact:
Grande West Transportation
John LaGourgue
VP Corporate Development
Ph: 604-288-8043
IR@grandewest.com
www.grandewest.com

Neither the TSX-V nor its Regulation Service Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Grande West Transportation Group

ReleaseID: 601088